Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial - PubMed

Aimmune Therapeutics.
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov